168 related articles for article (PubMed ID: 36439119)
1. Adjuvant alternative cytokine-induced killer cell combined with natural killer cell immunotherapy improves the prognosis of post-mastectomy breast cancer.
Yang X; Weng D; Pan Q; Xiang T; Yang C; Wu Z; Li M; Xie S; Tang Y; Xia J; Zhao J
Front Immunol; 2022; 13():974487. PubMed ID: 36439119
[TBL] [Abstract][Full Text] [Related]
2. Clinical activity of adjuvant cytokine-induced killer cell immunotherapy in patients with post-mastectomy triple-negative breast cancer.
Pan K; Guan XX; Li YQ; Zhao JJ; Li JJ; Qiu HJ; Weng DS; Wang QJ; Liu Q; Huang LX; He J; Chen SP; Ke ML; Zeng YX; Xia JC
Clin Cancer Res; 2014 Jun; 20(11):3003-11. PubMed ID: 24668644
[TBL] [Abstract][Full Text] [Related]
3. Adoptive cell therapy of triple negative breast cancer with redirected cytokine-induced killer cells.
Sommaggio R; Cappuzzello E; Dalla Pietà A; Tosi A; Palmerini P; Carpanese D; Nicolè L; Rosato A
Oncoimmunology; 2020 Jun; 9(1):1777046. PubMed ID: 32923140
[TBL] [Abstract][Full Text] [Related]
4. Combination of FAK inhibitor and cytokine-induced killer cell therapy: An alternative therapeutic strategy for patients with triple-negative breast cancer.
Wu CC; Pan MR; Shih SL; Shiau JP; Wu CC; Chang SJ; Kao CN; Chen FM; Hou MF; Luo CW
Biomed Pharmacother; 2023 Jul; 163():114732. PubMed ID: 37254289
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant cellular immunotherapy in patients with resected primary non-small cell lung cancer.
Pan QZ; Tang Y; Wang QJ; Li YQ; Zhang L; Li XD; Zhao JJ; Weng DS; Liu Q; Huang LX; He J; Chen SP; Ke ML; Zeng YX; Xia JC
Oncoimmunology; 2015 Sep; 4(9):e1038017. PubMed ID: 26405607
[TBL] [Abstract][Full Text] [Related]
6. PD-L1 expression is a predictive biomarker for CIK cell-based immunotherapy in postoperative patients with breast cancer.
Zhou ZQ; Zhao JJ; Pan QZ; Chen CL; Liu Y; Tang Y; Zhu Q; Weng DS; Xia JC
J Immunother Cancer; 2019 Aug; 7(1):228. PubMed ID: 31455411
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of adjuvant cytokine-induced killer cell immunotherapy in patients with colorectal cancer after radical resection.
Pan QZ; Zhao JJ; Yang CP; Zhou YQ; Lin JZ; Tang Y; Gu JM; Wang QJ; Li YQ; He J; Chen SP; Song MJ; Huang Y; Yang JY; Weng DS; Xia JC
Oncoimmunology; 2020; 9(1):1752563. PubMed ID: 32363125
[TBL] [Abstract][Full Text] [Related]
8. Retrospective analysis of the efficacy of adjuvant cytokine-induced killer cell immunotherapy combined with chemotherapy in colorectal cancer patients after surgery.
Li X; Zhou H; Huang W; Wang X; Meng M; Hou Z; Liao L; Tang W; Xie Y; Wang R; Yu H; Wang L; Zhu H; Wang W; Tan J; Li R
Clin Transl Immunology; 2022; 11(1):e1368. PubMed ID: 35079378
[TBL] [Abstract][Full Text] [Related]
9. The efficacy of cytokine-induced killer cell infusion as an adjuvant therapy for postoperative hepatocellular carcinoma patients.
Pan K; Li YQ; Wang W; Xu L; Zhang YJ; Zheng HX; Zhao JJ; Qiu HJ; Weng DS; Li JJ; Wang QJ; Huang LX; He J; Chen SP; Ke ML; Wu PH; Chen MS; Li SP; Xia JC; Zeng YX
Ann Surg Oncol; 2013 Dec; 20(13):4305-11. PubMed ID: 23892527
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the Clinical Efficacy of Dendritic Cell -cytokine Induced Killer Cell-based Adoptive Immunotherapy for Colorectal Cancer.
Xu H; Qin W; Feng H; Song D; Yang X; Zhang J
Immunol Invest; 2021 Aug; 50(6):622-633. PubMed ID: 32718264
[No Abstract] [Full Text] [Related]
11. Combination of radiofrequency ablation and sequential cellular immunotherapy improves progression-free survival for patients with hepatocellular carcinoma.
Cui J; Wang N; Zhao H; Jin H; Wang G; Niu C; Terunuma H; He H; Li W
Int J Cancer; 2014 Jan; 134(2):342-51. PubMed ID: 23825037
[TBL] [Abstract][Full Text] [Related]
12. Combined cellular immunotherapy and chemotherapy improves clinical outcome in patients with gastric carcinoma.
Cui J; Li L; Wang C; Jin H; Yao C; Wang Y; Li D; Tian H; Niu C; Wang G; Han W; Xu J; Chen J; Li W
Cytotherapy; 2015 Jul; 17(7):979-88. PubMed ID: 25890480
[TBL] [Abstract][Full Text] [Related]
13. Blocking LLT1 (CLEC2D, OCIL)-NKRP1A (CD161) interaction enhances natural killer cell-mediated lysis of triple-negative breast cancer cells.
Marrufo AM; Mathew SO; Chaudhary P; Malaer JD; Vishwanatha JK; Mathew PA
Am J Cancer Res; 2018; 8(6):1050-1063. PubMed ID: 30034942
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant treatment for triple-negative breast cancer: a retrospective study of immunotherapy with autologous cytokine-induced killer cells in 294 patients.
Zhang Y; Wang S; Yang B; Lu S; Du Y; Liu H
Cancer Biol Med; 2019 May; 16(2):350-360. PubMed ID: 31516755
[TBL] [Abstract][Full Text] [Related]
15. Cytokine-induced killer cells/dendritic cells-cytokine induced killer cells immunotherapy combined with chemotherapy for treatment of colorectal cancer in China: a meta-analysis of 29 trials involving 2,610 patients.
Zhang L; Mu Y; Zhang A; Xie J; Chen S; Xu F; Wang W; Zhang Y; Ren S; Zhou C
Oncotarget; 2017 Jul; 8(28):45164-45177. PubMed ID: 28404886
[TBL] [Abstract][Full Text] [Related]
16. Influence of the number and interval of treatment cycles on cytokine-induced killer cells and their adjuvant therapeutic effects in advanced non-small-cell lung cancer (NSCLC).
Gu Y; Lv H; Zhao J; Li Q; Mu G; Li J; Wuyang J; Lou G; Wang R; Zhang Y; Huang X
Int Immunopharmacol; 2017 Sep; 50():263-269. PubMed ID: 28711032
[TBL] [Abstract][Full Text] [Related]
17. 2003-2013, a valuable study: Autologous tumor lysate-pulsed dendritic cell immunotherapy with cytokine-induced killer cells improves survival in stage IV breast cancer.
Lin M; Liang S; Jiang F; Xu J; Zhu W; Qian W; Hu Y; Zhou Z; Chen J; Niu L; Xu K; Lv Y
Immunol Lett; 2017 Mar; 183():37-43. PubMed ID: 28143792
[TBL] [Abstract][Full Text] [Related]
18. Capecitabine metronomic chemotherapy combined with autologous CIK cell immunotherapy in the treatment of recurrent and metastatic triple-negative breast cancer.
Chen S; Yang Y; Jiao Y; Sun H; Yan Z
J BUON; 2021; 26(3):734-740. PubMed ID: 34268928
[TBL] [Abstract][Full Text] [Related]
19. Immunotherapy with cytokine-induced killer cells as an adjuvant treatment for advanced gastric carcinoma: a retrospective study of 165 patients.
Zhao H; Fan Y; Li H; Yu J; Liu L; Cao S; Ren B; Yan F; Ren X
Cancer Biother Radiopharm; 2013 May; 28(4):303-9. PubMed ID: 23506427
[TBL] [Abstract][Full Text] [Related]
20. Cytokine-induced killer cell/dendritic cell combined with cytokine-induced killer cell immunotherapy for treating advanced gastrointestinal cancer.
Du H; Yang J; Zhang Y
BMC Cancer; 2020 Apr; 20(1):357. PubMed ID: 32345239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]